1,051 followers
Inotuzumab ozogamicin: a CD22 mAb-drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia. https://t.co/GZ6dfBuL4P https://t.co/Rjd8gAMyXx
Inotuzumab ozogamicin: a CD22 mAb-drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia. https://t.co/GZ6dfBuL4P https://t.co/Rjd8gAMyXx
Delighted to share this review I wrote with Dr. Michaela Liedtke and Dr. Lori Muffly on inotuzumab ozogamicin, a monoclonal antibody that may be used to treat relapsed or refractory acute lymphoblastic leukemia. Open access PDF available on site @DovePress